MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 184 filers reported holding MYRIAD GENETICS INC in Q3 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $254,000 | -17.5% | 8,743 | +30.4% | 0.00% | 0.0% |
| Q3 2018 | $308,000 | +12.4% | 6,705 | -8.5% | 0.00% | 0.0% |
| Q2 2018 | $274,000 | +2.6% | 7,326 | -18.9% | 0.00% | 0.0% |
| Q1 2018 | $267,000 | +18.1% | 9,032 | +37.3% | 0.00% | 0.0% |
| Q4 2017 | $226,000 | -25.9% | 6,578 | -18.5% | 0.00% | 0.0% |
| Q1 2016 | $305,000 | +1.0% | 8,074 | +14.5% | 0.00% | 0.0% |
| Q4 2015 | $302,000 | -2.9% | 7,054 | -21.0% | 0.00% | -50.0% |
| Q1 2015 | $311,000 | -78.2% | 8,933 | -78.7% | 0.00% | -75.0% |
| Q4 2014 | $1,428,000 | -50.9% | 41,926 | -44.8% | 0.01% | -52.9% |
| Q3 2014 | $2,909,000 | +55.1% | 75,944 | +57.5% | 0.02% | +54.5% |
| Q2 2014 | $1,876,000 | +23.6% | 48,208 | +8.6% | 0.01% | +22.2% |
| Q1 2014 | $1,518,000 | +135.3% | 44,390 | +44.5% | 0.01% | +125.0% |
| Q4 2013 | $645,000 | – | 30,724 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SCOPIA CAPITAL MANAGEMENT LP | 6,459,139 | $278,776,000 | 5.53% |
| Tieton Capital Management, LLC | 119,290 | $5,149,000 | 4.04% |
| RPg Family Wealth Advisory, LLC | 97,202 | $4,195,238,000 | 3.85% |
| RK Capital | 384,900 | $16,612,000 | 2.90% |
| Contrarius Investment Management Ltd | 652,288 | $28,153,000 | 2.65% |
| S&T BANK/PA | 331,885 | $14,324,000 | 2.22% |
| Euclidean Technologies Management, LLC | 40,917 | $1,766,000 | 1.90% |
| AIMZ Investment Advisors, LLC | 45,635 | $1,970,000 | 1.80% |
| Taylor Frigon Capital Management LLC | 34,783 | $1,486,000 | 1.67% |
| KILLEN GROUP INC | 366,305 | $15,810,000 | 1.63% |